Jeffrey Lawrence Schwartz
CIK 1702957 · Chief Executive Officer · last filed 2025-09-08
Jeffrey Lawrence Schwartz is a Chief Executive Officer who has filed 17 SEC Form 4 insider transactions across 7 companies since 2017. The most recent filing, for KMTS, was dated Sep 8, 2025. Across all open-market trades the lifetime net is −$294.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $612.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$612.60M
7
17
-$294.42M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KMTS | Director | 27,030,134 | $20.85 | $563.58M | $0 | 1 | 2025-09-08 |
| RPID | Director | 8,448,860 | $1.76 | $14.87M | $0 | 4 | 2024-05-28 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 3,091,879 | $46.99 | $145.29M | -$320.07M | 8 | 2023-05-25 |
| BCLS Acquisition Corp. (BLSA) Delisted | Chief Executive Officer | 487,500 | $10.04 | $4.89M | $0 | 1 | 2020-10-26 |
| ANNX | 10%+ Owner | 2,841,628 | $4.71 | $13.38M | $40.80M | 1 | 2020-07-28 |
| REPL | 10%+ Owner | 2,338,968 | $8.88 | $20.77M | $45.00M | 1 | 2018-07-26 |
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | 10%+ Owner | 3,977,453 | $0.55 | $2.19M | -$60.15M | 1 | 2017-12-19 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-08 | KMTS | Grant (A) | +10,909 | $0 | EDGAR |
| 2024-05-28 | RPID | Grant (A) | +14,300 | $0 | EDGAR |
| 2023-05-25 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,648 | $0 | EDGAR |
| 2023-05-05 | RPID | Grant (A) | — | $0 | EDGAR |
| 2023-03-20 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −1,750,000 | -$49.88M | EDGAR |
| 2022-06-10 | RPID | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,818 | $0 | EDGAR |
| 2021-08-12 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −4,000,000 | -$281.00M | EDGAR |
| 2021-07-16 | RPID | Grant (A) | — | $0 | EDGAR |
| 2021-05-24 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +1,106 | $0 | EDGAR |